Skip to main content
. 2003 Jan 20;2003(1):CD003383. doi: 10.1002/14651858.CD003383

Lehmann 1998.

Methods Randomised, placebo‐controlled double‐blind;2 parallel groups
Participants Pre‐operative women (n=20); University hospital, Germany
Interventions 150 mg 3 times (150 mg kavalactones) daily for 1 week
Outcomes Responder ‐ non‐responder ratio. Differential reduction of anxiety in favour of kava (p<0.05)
Notes Adverse events (kava group): not detailed 
 Jadad score: 2
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear